Philip Jenkinson

701 total citations
22 papers, 421 citations indexed

About

Philip Jenkinson is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Philip Jenkinson has authored 22 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Philip Jenkinson's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (12 papers) and Biosimilars and Bioanalytical Methods (3 papers). Philip Jenkinson is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (12 papers) and Biosimilars and Bioanalytical Methods (3 papers). Philip Jenkinson collaborates with scholars based in United Kingdom, Netherlands and New Zealand. Philip Jenkinson's co-authors include Gareth‐Rhys Jones, Nikolas Plevris, Charlie W. Lees, Ian Arnott, Mathew Lyons, Colin Noble, Alan G. Shand, James Fulforth, Shahida Din and Gwo‐Tzer Ho and has published in prestigious journals such as Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Philip Jenkinson

17 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Jenkinson United Kingdom 10 308 247 137 107 39 22 421
Mariann Rutka Hungary 11 195 0.6× 145 0.6× 125 0.9× 123 1.1× 88 2.3× 51 398
Marta Vernero Italy 14 229 0.7× 199 0.8× 118 0.9× 96 0.9× 49 1.3× 37 485
Ágnes Milassin Hungary 10 164 0.5× 129 0.5× 104 0.8× 136 1.3× 65 1.7× 41 343
Nikolas Plevris United Kingdom 14 528 1.7× 423 1.7× 234 1.7× 177 1.7× 50 1.3× 53 699
Farhad Peerani Canada 8 344 1.1× 306 1.2× 166 1.2× 67 0.6× 23 0.6× 42 489
Marianne Kajbæk Vester-Andersen Denmark 15 407 1.3× 358 1.4× 193 1.4× 47 0.4× 29 0.7× 19 533
Ana Vieira Portugal 9 222 0.7× 154 0.6× 81 0.6× 91 0.9× 19 0.5× 12 301
J. Chao United States 8 546 1.8× 425 1.7× 198 1.4× 74 0.7× 28 0.7× 46 689
I. Arnott United Kingdom 7 269 0.9× 177 0.7× 208 1.5× 76 0.7× 92 2.4× 19 435
Davide Massimi Italy 11 125 0.4× 119 0.5× 77 0.6× 88 0.8× 45 1.2× 43 346

Countries citing papers authored by Philip Jenkinson

Since Specialization
Citations

This map shows the geographic impact of Philip Jenkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Jenkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Jenkinson more than expected).

Fields of papers citing papers by Philip Jenkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Jenkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Jenkinson. The network helps show where Philip Jenkinson may publish in the future.

Co-authorship network of co-authors of Philip Jenkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Jenkinson. A scholar is included among the top collaborators of Philip Jenkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Jenkinson. Philip Jenkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jenkinson, Philip, Beatriz Gros, Nikolas Plevris, et al.. (2023). Mo1782 ANALYSIS OF COLECTOMY RATES AND ADVANCED THERAPY PRESCRIBING FOR ULCERATIVE COLITIS IN LOTHIAN, SCOTLAND; AN UPDATED POPULATION BASED COHORT STUDY. Gastroenterology. 164(6). S–908. 1 indexed citations
2.
Plevris, Nikolas, Beatriz Gros, Mathew Lyons, et al.. (2022). Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease. Digestive and Liver Disease. 55(8). 1034–1041. 5 indexed citations
3.
4.
Siakavellas, Spyros I., Mathew Lyons, Nikolas Plevris, et al.. (2021). P155 88000 faecal calprotectin measurements over 15 years: insights gained from the edinburgh faecal calprotectin register. A123–A124. 3 indexed citations
5.
Siakavellas, Spyros I., Luke Williams, Philip Jenkinson, et al.. (2021). OP22 Factors independently associated with fatigue in IBD: Results from the baseline dataset of the PREdiCCt study. Journal of Crohn s and Colitis. 15(Supplement_1). S021–S021. 1 indexed citations
6.
Plevris, Nikolas, Mathew Lyons, Spyros I. Siakavellas, et al.. (2021). Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts. Journal of Crohn s and Colitis. 15(12). 2011–2021. 29 indexed citations
7.
Banerjee, Anjan K., et al.. (2020). Colon capsule endoscopy. The Surgeon. 18(4). 251–256. 15 indexed citations
8.
Plevris, Nikolas, James Fulforth, Mathew Lyons, et al.. (2020). Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 19(9). 1835–1844.e6. 26 indexed citations
9.
Jenkinson, Philip, Nikolas Plevris, Mathew Lyons, et al.. (2020). Analysis of colectomy rates for ulcerative colitis in pre‐ and postbiological eras in Lothian, Scotland. Colorectal Disease. 23(5). 1175–1183. 9 indexed citations
10.
Plevris, Nikolas, James Fulforth, Philip Jenkinson, et al.. (2020). 401 NORMALIZATION OF FECAL CALPROTECTIN WITHIN 12 MONTHS OF DIAGNOSIS IS ASSOCIATED WITH A REDUCED RISK OF DISEASE PROGRESSION IN CROHNS DISEASE. Gastroenterology. 158(6). S–74. 1 indexed citations
11.
Jenkinson, Philip, Nikolas Plevris, Spyros I. Siakavellas, et al.. (2020). Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn’s Disease: A Population-based Cohort Study. Journal of Crohn s and Colitis. 14(9). 1241–1247. 21 indexed citations
12.
Jones, Gareth‐Rhys, Nikolas Plevris, Philip Jenkinson, et al.. (2020). The ACE (Albumin, CRP and Endoscopy) Index in Acute Colitis: A Simple Clinical Index on Admission that Predicts Outcome in Patients With Acute Ulcerative Colitis. Inflammatory Bowel Diseases. 27(4). 451–457. 44 indexed citations
13.
Jones, Gareth‐Rhys, Mathew Lyons, Nikolas Plevris, et al.. (2019). OWE-04 A capture-recapture study of all-age IBD point prevalence in scotland. A63–A64.
14.
Jones, Gareth‐Rhys, Mathew Lyons, Nikolas Plevris, et al.. (2019). IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology. Gut. 68(11). 1953–1960. 137 indexed citations
15.
Plevris, Nikolas, Philip Jenkinson, Mathew Lyons, et al.. (2019). Association of trough vedolizumab levels with clinical, biological and endoscopic outcomes during maintenance therapy in inflammatory bowel disease. Frontline Gastroenterology. 11(2). 117–123. 13 indexed citations
16.
Plevris, Nikolas, Philip Jenkinson, Ian Arnott, Gareth‐Rhys Jones, & Charlie W. Lees. (2019). Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn’s disease. European Journal of Gastroenterology & Hepatology. 32(1). 32–37. 51 indexed citations
17.
Plevris, Nikolas, Philip Jenkinson, Mathew Lyons, et al.. (2018). DOP072 Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn’s disease cohort. Journal of Crohn s and Colitis. 12(supplement_1). S079–S080.
18.
Plevris, Nikolas, Gareth‐Rhys Jones, Philip Jenkinson, et al.. (2018). Implementation of CT-P13 via a Managed Switch Programme in Crohn’s Disease: 12-Month Real-World Outcomes. Digestive Diseases and Sciences. 64(6). 1660–1667. 28 indexed citations
19.
Plevris, Nikolas, Mathew Lyons, Philip Jenkinson, et al.. (2018). Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn’s Disease Are Associated With Biologic Remission. Inflammatory Bowel Diseases. 25(6). 1036–1043. 23 indexed citations
20.
Jenkinson, Philip, et al.. (2014). Progressive, reversible sensorineural hearing loss caused by azathioprine. The Journal of Laryngology & Otology. 128(9). 838–840. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariann Rutka Breakdown of academic impact, for papers by Marta Vernero Breakdown of academic impact, for papers by Ágnes Milassin Breakdown of academic impact, for papers by Nikolas Plevris Breakdown of academic impact, for papers by Farhad Peerani Breakdown of academic impact, for papers by Marianne Kajbæk Vester-Andersen Breakdown of academic impact, for papers by Ana Vieira Breakdown of academic impact, for papers by J. Chao Breakdown of academic impact, for papers by I. Arnott Breakdown of academic impact, for papers by Davide Massimi
Rankless by CCL
2026